• 5-HT2C/1A Receptor Roles in DOM-Induced Head Twitch Response

  2026-06-25

  This study elucidates how 5-HT2C and 5-HT1A serotonin receptors modulate the biphasic, dose-dependent effects of DOM on head twitch and locomotor activity in mice. The findings clarify mechanistic underpinnings of serotonergic hallucinogen action, informing both neuropharmacology and behavioral assay design.

• Gamma-linolenic Acid (GLA): Mechanisms, Evidence & Use Cases

  2026-06-24

  Gamma-linolenic acid (GLA) is an omega-6 polyunsaturated fatty acid with verified anti-inflammatory and cytotoxic properties. As a weak leukotriene B4 receptor antagonist, it modulates inflammatory responses and supports research in atopic dermatitis and neuropathy. This article details GLA’s biochemical mechanisms, evidence base, and best-practice integration.

• Auranofin: Redox Disruption and Radiosensitization in Cancer

  2026-06-23

  This thought-leadership article explores Auranofin’s role as a thioredoxin reductase inhibitor, dissecting its mechanistic underpinnings in redox modulation, apoptosis induction, and radiosensitization. Strategic guidance is provided for translational researchers, with protocol parameters, cross-domain context, and a visionary outlook on integrating metabolic targeting, referencing both recent breakthroughs and APExBIO’s Auranofin product.

• Demethyleneberberine: Mechanistic Insights for Neuroprotecti

  2026-06-23

  Explore the multifaceted bioactivity of Demethyleneberberine (DMB), a potent anti-inflammatory and neuroprotective compound, with a detailed analysis of its mechanisms and practical applications. This article delivers advanced, evidence-grounded guidance for integrating DMB into complex disease models.

• CYR61-Migrasome Axis Restores Osteogenic Function in IR BMSC

  2026-06-22

  The reference study demonstrates that the extracellular matrix protein CYR61, delivered via migrasomes, promotes both migration and osteoblastic differentiation in irradiated bone marrow mesenchymal stem cells (BMSCs). These findings offer mechanistic insight into cellular recovery after radiation and suggest a potential target for treating osteoradionecrosis of the jaw.

• Adiponectin-Driven APPL1 Nuclear Translocation: Key to Rapid

  2026-06-22

  This study uncovers how a single bout of exercise rapidly alleviates depressive behavior in mice by triggering adiponectin-induced APPL1 nuclear translocation in anterior cingulate cortex (ACC) glutamatergic neurons. The findings clarify a novel molecular cascade linking acute physical activity to rapid antidepressant effects, highlighting AdipoR1 as a potential therapeutic target.

• AI-10-49: Precision CBFβ-SMMHC Inhibition in AML Research

  2026-06-21

  AI-10-49 enables targeted disruption of the CBFβ-SMMHC fusion protein, restoring RUNX1 activity and selectively inhibiting inv(16) acute myeloid leukemia cell survival. This article details advanced workflows, experimental optimizations, and troubleshooting approaches, translating the latest mechanistic insights into actionable research protocols.

• Bradykinin as an Endothelium-Dependent Vasodilator: Lab Guid

  2026-06-20

  Bradykinin (SKU BA5201) is a potent endothelium-dependent vasodilator peptide used in cardiovascular, inflammation, and pain mechanism research. It enables reliable modeling of vascular permeability and smooth muscle contraction responses. This reagent should not be used in diagnostic or clinical workflows, and its stability demands careful handling in experimental settings.

• N-MYC/eIF4G1 Axis in inv(16) AML: New Mechanistic Insights

  2026-06-19

  Peramangalam et al. uncover that N-MYC, regulated by a novel enhancer, sustains cell survival in inv(16) acute myeloid leukemia via the translational factor eIF4G1. Their work highlights the therapeutic potential of targeting the CBFβ-SMMHC/N-MYC/eIF4G1 pathway, supporting refined strategies in acute myeloid leukemia research.

• TRPV1 Modulation Alters Immune Response in Breast Cancer Mod

  2026-06-19

  This study investigates how in vitro activation or inhibition of TRPV1 channels alters the immune response in mice bearing metastatic breast carcinoma. The findings reveal that TRPV1 agonists can enhance inflammatory cytokine production in tumor-bearing mice, indicating complex immunomodulatory effects that may affect the therapeutic potential of TRPV1-targeted interventions.

• Artesunate: Mechanisms and Benchmarks in Cancer Research

  2026-06-18

  Artesunate, a semi-synthetic artemisinin derivative, is a potent anticancer compound with efficacy in lung and esophageal carcinoma models. Its mechanisms involve inhibition of caspase-11-mediated pyroptosis and induction of ferroptosis. Well-characterized workflow parameters and robust benchmarks support its use in in vitro oncology research.

• SINAT Proteins Control Autophagic Vesicle Degradation in Ara

  2026-06-18

  This study elucidates how SINAT proteins regulate autophagic vesicle degradation in Arabidopsis by targeting the V-ATPase subunit VAB1 for ubiquitination and proteolysis. The findings provide new mechanistic insight into plant autophagy, highlighting the importance of SINAT-mediated VAB1 turnover for efficient vacuolar degradation and cellular adaptation to nutrient stress.

• Intravesical p21 mRNA-LNP Therapy: A New Approach for Bladde

  2026-06-17

  This study demonstrates that localized delivery of p21 mRNA-loaded lipid nanoparticles (LNPs) via intravesical instillation can restore tumor suppressor function and suppress tumor growth in bladder cancer models. The findings highlight a clinically adaptable, non-viral strategy for targeted mRNA-based cancer therapy with meaningful advantages over systemic approaches.

• Podophyllotoxin Derivative 5p: Dual-Target Strategy Against

  2026-06-17

  The referenced study introduces a novel podophyllotoxin derivative, 5p, that simultaneously inhibits topoisomerase IIα and microtubule polymerization, effectively overcoming multidrug resistance (MDR) in various cancer models. This dual-target approach provides new mechanistic insights for anticancer drug research and highlights the therapeutic promise of structurally modified podophyllotoxins.

• Alternariol Drives Hepatic Stellate Cell Transdifferentiatio

  2026-06-16

  This study leverages omics-based analysis to clarify how Alternariol (AOH) and related Alternaria toxins directly induce hepatic stellate cell activation, a core driver of liver fibrosis. The work not only elucidates key molecular pathways but also introduces a laccase-based detoxification strategy, creating new avenues for mycotoxin research and risk mitigation.

443 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page